Pre-Conference Workshops
Tuesday, October 19, 2021


Turning Cold Tumors Hot Through Novel Combination Approaches
10.00 am - 12.00 pm

Beyond T Cells: Understanding the Ecosystem of Hot Tumors

  • Review the cellular components of hot versus cold tumor microenvironments, and the underlying tumor-intrinsic genomic features
  • Describe the role of B cells and plasma cells in anti-tumor immunity
  • Discuss how orthogonal immune mechanisms can synergize to control tumors

Combination with TILs to Improve Outcomes

  • Outline current progress with TILs plus targeted therapy
  • Assess results of TILs plus checkpoint inhibitors
  • Question how to position combos with TILs in the current treatment arena

Workshop Leaders

Marco Donia

Marco Donia
Research Group Leader
Herlev Hospital

Brad Nelson Feb 2021

Brad Nelson
Director & Distinguished Scientist
BC Cancer Deeley Research Centre


QC & Potency Assay Development to Bridge Clinical Data and Remove Variability
1.00 pm - 3.00 pm

Early Phase Cell Therapy Product Development: Potency Assays

  • Acquire knowledge of the regulatory expectations for potency assay rigor in early or late phase clinical trials
  • Observe relevant examples of potency assay application for a representative cell therapy product
  • Determine when and what test methods to apply during cell therapy product characterization and validation

Workshop Leader

Cheryl Cox

Cheryl Cox
Cell Therapy Core Operations Director
Moffitt Cancer Center